Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Silverback Therapeutics (SBTX)
NASDAQ:SBTX
Silverback Therapeutics (SBTX) Financial Statements
0 Followers
Silverback Therapeutics Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -18.62M | $ -19.80M | $ -24.70M | $ -23.51M | $ -22.68M |
| EBITDA | $ -18.52M | $ -19.57M | $ -24.49M | $ -23.32M | $ -22.48M |
| Net Income Common Stockholders | $ -17.86M | $ -19.43M | $ -24.63M | $ -23.46M | $ -22.66M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 266.62M | $ 257.98M | $ 253.85M | $ 254.04M | $ 300.66M |
| Total Assets | $ 271.06M | $ 294.00M | $ 312.47M | $ 333.47M | $ 352.56M |
| Total Debt | $ 215.00K | $ 4.95M | $ 5.55M | $ 5.85M | $ 6.17M |
| Net Debt | $ -266.41M | $ -253.03M | $ -248.29M | $ -248.20M | $ -294.49M |
| Total Liabilities | $ 3.99M | $ 15.21M | $ 19.24M | $ 19.65M | $ 20.43M |
| Stockholders Equity | $ 267.07M | $ 278.79M | $ 293.23M | $ 313.81M | $ 332.13M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -16.65M | $ -15.44M | $ -20.07M | $ -21.86M | $ -19.21M |
| Operating Cash Flow | $ -16.58M | $ -15.15M | $ -19.74M | $ -21.30M | $ -19.12M |
| Investing Cash Flow | $ -66.00K | $ -286.00K | $ -332.00K | $ -25.68M | $ -40.06M |
| Financing Cash Flow | $ 1.18M | $ 139.00K | $ 19.00K | $ 275.00K | $ 148.00K |
Silverback Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.